{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:42:17Z","timestamp":1791495737160,"version":"4.3.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3321,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.1995.tb05022.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T12:45:37Z","timestamp":1279716337000},"page":"257-262","source":"Crossref","is-referenced-by-count":77,"title":["Cimetidine improves the therapeutic\/toxic ratio of dapsone in patients on chronic dapsone therapy"],"prefix":"10.1093","volume":"132","author":[{"given":"L.E.","family":"Rhodes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Tingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.K.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Verbov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,7,29]]},"reference":[{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJM199305273282102","article-title":"et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophy-laxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection","volume":"328","author":"Girard","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/1040-0486(91)90003-M","article-title":"Dermatitis herpetiformis","volume":"3","author":"Zone","year":"1991","journal-title":"Curr Probl Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0190-9622(79)80088-2","article-title":"Sulfones and sulfonamides in dermatology today","volume":"1","author":"Lang","year":"1979","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB4|cit4","first-page":"165","article-title":"The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency","volume":"35","author":"DeGowin","year":"1966","journal-title":"Bull WHO"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003088-198611040-00003","article-title":"Clinical pharmacokinetics of dapsone","volume":"11","author":"Zuidema","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archderm.1984.01650480044015","article-title":"et al. Vitamin E and dapsone-induced haemolysis","volume":"120","author":"Kelly","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archderm.1992.01680120082007","article-title":"The protective effect of vitamin E on the haemolysis associated with dapsone treatment in patients with dermatitis herpetiformis","volume":"128","author":"Prussick","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3565(25)29658-6","article-title":"et al. Studies of the metabolism of dapsone in man and experimental animals. Formation of N-hydroxy metabolites","volume":"187","author":"Israili","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4269\/ajtmh.1972.21.322","article-title":"Microsomal N-oxidation of dapsone as a cause of methaemoglobin formation in human red cells","volume":"21","author":"Cucinell","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2133.1979.tb01644.x","article-title":"Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage","volume":"100","author":"Manfredi","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0022-3565(25)24263-X","article-title":"Role of dapsone hydroxylamine in dapsone-induced haemolytic anaemia","volume":"244","author":"Grossman","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0041-008X(92)90239-O","article-title":"Dapsone-induced haemolytic anaemia: effect of N-hydroxy dapsone on the sulphydryl status and membrane proteins of rat erythrocytes","volume":"117","author":"Grossman","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1523-1747.ep12555654","article-title":"Dapsone suppresses integrin-mediated neutrophil adherence function","volume":"98","author":"Booth","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/1523-1747.ep12471811","article-title":"Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses","volume":"100","author":"Thuong-Nguyen","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0022-3565(25)22309-6","article-title":"Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells","volume":"245","author":"Uetrecht","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/0016-5085(91)90408-D","article-title":"Differential inhibition of individual human liver cytochromes P-450 by cimetidine","volume":"101","author":"Knodell","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/clpt.1990.204","article-title":"The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects","volume":"48","author":"May","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0026-895X(25)09189-8","article-title":"Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4","volume":"41","author":"Fleming","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2125.1991.tb05623.x","article-title":"The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes","volume":"32","author":"Tingle","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0090-9556(25)07797-9","article-title":"Cimetidine and dapsone acetylation","volume":"12","author":"Wright","year":"1984","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2125.1990.tb03847.x","article-title":"The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man","volume":"30","author":"Coleman","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2125.1992.tb04131.x","article-title":"The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients","volume":"34","author":"Coleman","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0022-3565(25)24384-1","article-title":"Role of aniline metabolites in aniline-induced haemolytic anaemia","volume":"238","author":"Harrison","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB24|cit24","first-page":"109","volume-title":"Practical Haematology","author":"Dacie","year":"1984"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0019-2791(65)90004-2","article-title":"Immunocytochemical quantification of antigens by single radial immunodiffusion","volume":"2","author":"Mancini","year":"1965","journal-title":"Immunocytochemistry"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB26|cit26","first-page":"144","volume-title":"Medical Statistics","author":"Dacie","year":"1984"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-93-6-857","article-title":"Dermatitis herpetiformis: the skin and the gut","volume":"93","author":"Katz","year":"1980","journal-title":"Ann Inter Med"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00007890-199102000-00018","article-title":"Cyclosporin dose reduction by ketconazole administration in renal transplant recipients","volume":"51","author":"First","year":"1991","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2133.1995.tb05022.x-BIB29|cit29","first-page":"426","article-title":"et al. Cimetidine reduces dapsone-induced haematological toxicity in dermatitis herpetiformis","volume":"127","author":"Rhodes","year":"1992","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.1995.tb05022.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.1995.tb05022.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T01:01:36Z","timestamp":1740272496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/132\/2\/257\/6680784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,29]]},"references-count":29,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb05022.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,29]]}}}